HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefano Molica Selected Research

Residual Neoplasm

12/2021A perspective on prognostic models in chronic lymphocytic leukemia in the era of targeted agents.
6/2021Current and emerging investigational venetoclax-based therapies in chronic lymphocytic leukemia.
1/2020The Evolution of Targeted Therapies in Chronic Lymphocytic Leukaemia.
1/2017Ibrutinib continues to influence the therapeutic landscape of chronic lymphocytic leukemia: new data presented at ASCO 2017.
10/2007Intense reversal of bone marrow angiogenesis after sequential fludarabine-induction and alemtuzumab-consolidation therapy in advanced chronic lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stefano Molica Research Topics

Disease

73B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2022 - 01/2002
17Neoplasms (Cancer)
01/2021 - 11/2002
10Disease Progression
12/2021 - 06/2003
8Multiple Myeloma
10/2015 - 01/2002
6Infections
10/2022 - 11/2012
6Lymphocytosis
10/2015 - 07/2004
5Residual Neoplasm
12/2021 - 10/2007
4Anemia
04/2018 - 01/2002
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2017 - 08/2004
4Hodgkin Disease (Hodgkin's Disease)
10/2017 - 12/2003
4Leukemia
01/2015 - 07/2004
3Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
11/2016 - 01/2009
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2014 - 01/2005
2COVID-19
01/2022 - 01/2021
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2018 - 05/2018
2Hemorrhage
10/2018 - 10/2015
2Atrial Fibrillation
10/2018 - 10/2015
2Lymphoma (Lymphomas)
05/2018 - 10/2009
2Primary Myelofibrosis (Myelosclerosis)
04/2018 - 08/2004
2Breast Neoplasms (Breast Cancer)
01/2017 - 09/2003
2Hematologic Neoplasms (Hematological Malignancy)
04/2012 - 07/2003
1Agammaglobulinemia (Hypogammaglobulinemia)
08/2022
1Chronic Obstructive Pulmonary Disease (COPD)
06/2021
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2021
1Trisomy (Trisomies)
06/2019
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
10/2018
1Thrombocytopenia (Thrombopenia)
05/2018
1Diarrhea
05/2018
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2018
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
11/2017
1Ovarian Neoplasms (Ovarian Cancer)
01/2017
1Melanoma (Melanoma, Malignant)
01/2017
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2017
1Sarcoma (Soft Tissue Sarcoma)
01/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017
1Agranulocytosis (Granulocytopenia)
01/2017
1Cytopenia
11/2016
1Chromosome Aberrations (Chromosome Abnormalities)
03/2015

Drug/Important Bio-Agent (IBA)

23ibrutinibIBA
01/2022 - 10/2013
15Biological ProductsIBA
06/2019 - 01/2006
12Rituximab (Mabthera)FDA Link
12/2021 - 05/2014
7fludarabineIBA
11/2020 - 05/2005
6venetoclaxIBA
06/2021 - 01/2018
5Biomarkers (Surrogate Marker)IBA
12/2021 - 04/2005
5Agammaglobulinaemia Tyrosine KinaseIBA
01/2021 - 10/2013
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2020 - 09/2002
4Bendamustine HydrochlorideFDA Link
11/2020 - 11/2014
4Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2018 - 01/2008
4Bleomycin (Blenoxane)FDA LinkGeneric
04/2009 - 09/2002
3COVID-19 VaccinesIBA
08/2022 - 01/2022
3obinutuzumabIBA
01/2021 - 01/2015
3Chlorambucil (Leukeran)FDA Link
01/2017 - 05/2005
3Alemtuzumab (Campath)FDA Link
02/2014 - 10/2007
3Hemoglobins (Hemoglobin)IBA
01/2011 - 01/2002
3Vinblastine (Vinblastine Sulfate)FDA Link
04/2009 - 12/2003
2Messenger RNA (mRNA)IBA
03/2022 - 01/2022
2Phosphotransferases (Kinase)IBA
01/2021 - 11/2016
2idelalisibIBA
01/2018 - 06/2015
2Monoclonal AntibodiesIBA
01/2018 - 01/2017
2Imatinib Mesylate (Gleevec)FDA Link
12/2017 - 04/2014
2Brentuximab VedotinIBA
11/2017 - 10/2017
2Proteins (Proteins, Gene)FDA Link
03/2015 - 01/2015
2Melphalan (Alkeran)FDA LinkGeneric
04/2014 - 09/2003
2Bortezomib (Velcade)FDA Link
11/2012 - 01/2011
2Doxorubicin (Adriamycin)FDA LinkGeneric
04/2009 - 01/2006
2AdiponectinIBA
01/2009 - 11/2008
2Prednisone (Sone)FDA LinkGeneric
01/2006 - 09/2002
2Vincristine (Oncovin)FDA LinkGeneric
01/2006 - 09/2002
1Immunoglobulin G (IgG)IBA
10/2022
1BNT162 VaccineIBA
01/2022
1acalabrutinibIBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
11/2020
1ofatumumabFDA Link
11/2020
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2019
1Antiviral Agents (Antivirals)IBA
11/2018
1AnticoagulantsIBA
10/2018
1Pharmaceutical PreparationsIBA
10/2018
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
10/2018
1DeferasiroxFDA Link
04/2018
1ruxolitinibIBA
04/2018
1Glycoproteins (Glycoprotein)IBA
03/2018
1Immunoglobulins (Immunoglobulin)IBA
03/2018
1CD20 AntigensIBA
01/2018
1Tyrosine Kinase InhibitorsIBA
12/2017
1Lenalidomide (CC 5013)FDA Link
01/2017
1Immune Checkpoint InhibitorsIBA
01/2017
1ublituximabIBA
01/2017
1Thymidine KinaseIBA
01/2016
1Biosimilar PharmaceuticalsIBA
10/2015
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2015
1Filgrastim (Neupogen)FDA Link
10/2015
1betaglycan (TGFBR3)IBA
08/2015

Therapy/Procedure

33Therapeutics
08/2022 - 01/2002
11Drug Therapy (Chemotherapy)
01/2021 - 07/2003
3Immunotherapy
05/2018 - 04/2014
2Radiotherapy
04/2009 - 01/2006
2Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
07/2003 - 11/2002
1Immunomodulation
10/2022
1Time-to-Treatment
06/2019
1Salvage Therapy
01/2018